Access Bio CareStart COVID-19 MDx RT-PCR Test
Ask our experts
Description
The CareStart™ COVID-19 MDx RT-PCR molecular test provides a critical new resource in the fight against COVID-19 with a processing time of approximately 83 minutes.
The CareStart™ COVID-19 MDx RT-PCR test is an FDA EUA authorized molecular test for distribution and use by healthcare professionals and health systems conducting COVID-19 testing with 100% PPA/NPA results.
Analysis can be run on some of the most common PCR processing machines, such as Bio-Rad’s CFX96 Dx system, Thermo Fisher Scientific’s Applied Biosystems 7500, or 7500 Fast RT-PCR instrument.
Features
- Detect two gene regions and simultaneously detect N gene as well as RdRP gene of SARS-2 CoV.
- Preventing contamination using the UDG (UracilDNA Glycosylase System).
- Internal control included for sample extraction and amplification efficiency verification
- Reaction time within 83 minutes improving laboratory efficiency.
Product Specifications and Resources
Analyte | 2019-Novel CoV (COVID-19) |
Specimen type | Nasopharyngeal swab, Oropharyngeal swab |
Sample volume | 10 μL RNA |
Storage | Below -20°C |
Shelf-life | 6 months |
Internal control | Endogenous internal control included |
Quality control | Positive control, Negative control |
4 X 1 step RT-PCR Mix | |
2019-nCoV primer/probe Mix | |
Nuclease Free Water | |
MS2 Phage Control | |
Positive control | |
Negative control | |
IFU |